Minimum time interval adjustment for 4-3-1 immunization rates among two- year-old children

American Journal of Preventive Medicine

Volumn 16, Issue 3, 1999, Pages 189-194

  Steiner, R Prasaad ^a   Hughes, Judith A ^b   Richardson, Terry L ^b   Looney, Stephen W ^a   Clover, Richard D ^a   Rowe, Melinda G ^a,b  

^a University of Louisville School of Medicine   (United States)

^b Off for Comm Hlth Res/E   (United States)

Author keywords

Community; Health status; Immunization; Pediatrics; Preventive medicine; Vaccine (specific name)

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CHILD; COMMUNITY CARE; FEMALE; HEALTH STATUS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PEDIATRICS; POPULATION RESEARCH; PREVENTIVE MEDICINE; RETROSPECTIVE STUDY; RISK ASSESSMENT; VACCINATION;

CHILD, PRESCHOOL; DATA COLLECTION; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; KENTUCKY; MALE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; POLIOVIRUS VACCINE, ORAL; RETROSPECTIVE STUDIES; RUBELLA VACCINE; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VACCINATION; VACCINES, COMBINED;

EID: 0033121174     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(98)00095-6     Document Type: Article

References (17)

1. USDHHS (U.S. Department of Health and Human Services), Healthy People 2000: National Health Promotion and Disease Prevention Objectives. DHHD Pub. No. (PHS) 91-50212, Washington D.C., Office of the Assistant Secretary for Health, 1991.
2. Durch J.S., Bailey L.A., Stoto M.A., Improving Health in the Community: A Role for Performance Monitoring, Institute of Medicine. 1997;National Academy Press, Washington, DC.
3. Atkinson W., Gantt J., Mayfield M., Furphy L., Epidemiology and Prevention of Vaccine-preventable Diseases, Department of Health and Human Services. 1995;24 Public Health Service, Washington, DC.
4. American Academy of Pediatrics Committee on Infectious Diseases. Report of the Committee on Infectious Diseases, 22nd Ed. 1991;American Academy of Pediatrics, Elk Grove, IL.
5. CDC. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1989; 205-14, 219-27.
6. CDC. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. RR-1:(43):1994;1-38.
7. Fairbrother G., Friedman S., DuMont K.A., Lobach K.S. Markers for primary care: Missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city medicaid-eligible children. Pediatrics. 97:(6; Part 1):1996;785-790.
8. Ball T.M., Serwint J.R. Missed opportunities for vaccination and the delivery of preventive care. Arch Pediatr Adolesc Med. 150:(8):1996;858-861.
9. Dietz V.J., Stevenson J., Zell E.R., Cochi S., Hadler S., Eddins D. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med. 148:(9):1994;943-949.
10. Lieu T.A., Black S.B., Sorel M.E., Ray P., Shinefield H.R. Would better adherence to guidelines improve childhood immunization rates? Pediatrics. 98:(6 Pt 1):1996;1062-1068.
11. Taylor J.A., Darden P.M., Slora E., Hasemeier C.M., Asmussen L., Wasserman R. The influence of provider behavior, parental characteristics, and a public policy initiative on the immunization status of children followed by private pediatricians: A study from Pediatric Research in office settings. Pediatrics. 99:(2):1997;209-215.
12. Cohen D.I., Littenberg B., Wetzel C., Neuhauser D. Improving physician compliance with preventive medicine guidelines. Med Care. 20:(10):1982;1040-1045.
13. Alemi F., Alemagno S.A., Goldhagen J., et al. Computer reminders improve on time immunization rates. Med Care. 34:(Suppl 10):1996;OS45-OS51.
14. Patriarca P.A., Wright P.F., John T.J. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review. Rev Infect Dis. 13:(5):1991;926-939.
15. Comstock G.W. Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiol Rev. 16:(1):1994;77-89.
16. Marks J.S., Haden G.F., Orenstein W.A. Methodologic issues in the evaluation of vaccine effectiveness: Measles vaccine at 12 vs. 15 months. Am J Epidemiol. 116:(3):1982;510-523.
17. Christie C.D., Marx M.L., Marchant C.D., Resising S.F. The 1993 epidemic of pertussis in Cincinnati - Resurgence of disease in a highly immunized population of children. N Engl J Med. 331:(1):1994;16-21.